The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Amgen Europe B.V.EU/1/01/185/021-022

Main Information

Trade NameAranesp
Active SubstancesDarbepoetin alfa
Dosage FormSolution for injection in pre-filled syringe
Licence HolderAmgen Europe B.V.
Licence NumberEU/1/01/185/021-022

Group Information

ATC CodeB03XA Other antianemic preparations


License statusAuthorised
Licence Issued
Legal status*** AWAITING VALUE ***
Supply Status*** AWAITING VALUE ***
Advertising Status*** AWAITING VALUE ***
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back